Gwangmyeong-si, South Korea

Jun Young Choi

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.2

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Gwangmyeong-si, KR (2017 - 2020)
  • Gyeonggi-do, KR (2020 - 2022)
  • Seoul, KR (2022 - 2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jun Young Choi

Introduction

Jun Young Choi is a prominent inventor based in Gwangmyeong-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 12 patents to his name, Choi's work focuses on advanced therapeutic methods and compositions.

Latest Patents

One of his latest patents is a method for treating or sensitizing interferon beta resistant cancer using cFLIP siRNA. This invention relates to a pharmaceutical composition that includes an siRNA that binds to the mRNA of the cFLIP gene, along with a human interferon beta variant. Another notable patent is for an anti-c-Met agonist antibody, which specifically binds to a human-derived c-Met protein. This invention has applications in cancer treatment and stem cell differentiation.

Career Highlights

Choi has worked with notable organizations such as Abion Inc. and Seoul National University. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Choi has collaborated with esteemed colleagues, including Young Kee Shin and Sung Youl Hong. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Jun Young Choi's innovative work in cancer treatment and his impressive portfolio of patents highlight his dedication to advancing medical science. His contributions continue to influence the field and offer hope for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…